MEDTRONIC PLCMDT
ASignal's systematic analysis rates MDT as Neutral.
Reflects the latest available analysis · analyzed Oct 29, 2026
The case on MDT
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong gross margin of 65.27% indicating pricing power
- Free cash flow of $5.41B supports financial flexibility
- Debt-to-equity ratio of 0.55x, within healthy range
- Revenue growth of 13.7% year-over-year
- Earnings growth of 40.7% year-over-year
- MACD above signal line with expanding histogram, indicating bullish momentum
- RSI at 66.84, approaching overbought territory
- Slight negative price momentum (-0.007)
- Dividend yield of 307% is an outlier and likely data error
- Only two news sources reported, limited sentiment coverage
- No Reddit mentions, suggesting low retail investor interest
Peers
Clustered with MDT by analysis-profile similarity.
See the full verdict on MDT
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes MDT
Most investors never get a second opinion, let alone several. ASignal runs MDT past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.